Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 11, 2023 07:00 ET | Source: Cytovance Biologics

Cytovance Biologics and Phenotypeca Collaborate to Enhance Saccharomyces cerevisiae Strain Development for Microbial Biomanufacturing

OKLAHOMA CITY, March 11, 2023 (GLOBE NEWSWIRE) -- Cytovance Biologics, Inc. (Cytovance Biologics), a biopharmaceutical contract development and manufacturing organization (CDMO), and Phenotypeca...
January 16, 2023 07:30 ET | Source: Cytovance Biologics

Cytovance Biologics Announces Ping Zhang as Chief Executive Officer

OKLAHOMA CITY, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian and microbial biologics,...
June 14, 2021 03:00 ET | Source: Cytovance Biologics

Cytovance Biologics announces Plasmid DNA Manufacturing: An Optimized Platform Process Webinar

OKLAHOMA CITY, June 14, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial and gene therapy...
March 08, 2021 03:00 ET | Source: Cytovance Biologics

Cytovance Biologics now offering Licensing for Plasmid DNA Manufacturing

OKLAHOMA CITY, March 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
February 08, 2021 03:00 ET | Source: Cytovance Biologics

Cytovance Biologics announces Regulatory Strategies for Gene Therapy Product Development webinar

OKLAHOMA CITY, Okla., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial and gene...
November 30, 2020 03:00 ET | Source: Cytovance Biologics

Cytovance Biologics offers Nature Technology Corporation’s proprietary HyperGRO™ manufacturing platform for plasmid DNA CGMP manufacturing

OKLAHOMA CITY, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian, microbial biologics and...
November 09, 2020 03:00 ET | Source: Cytovance Biologics

Cytovance Biologics Announces Bin Zhang as Chief Executive Officer

OKLAHOMA CITY, Nov. 09, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO) of mammalian and microbial biologics,...
July 15, 2020 03:00 ET | Source: Cytovance Biologics

Cytovance Biologics Announces an Investment in Mass Spectrometry Services

OKLAHOMA CITY, July 15, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the addition of Mass...
July 13, 2020 03:00 ET | Source: Cytovance Biologics

Cytovance Biologics Promotes John Mott to Vice President of Development

OKLAHOMA CITY, July 13, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces the promotion of Dr. John...
July 06, 2020 03:00 ET | Source: Cytovance Biologics

Cytovance Biologics Announces Yuk Chun Chiu as Vice President of Manufacturing Operations

OKLAHOMA CITY, July 06, 2020 (GLOBE NEWSWIRE) -- Cytovance® Biologics, a leading biopharmaceutical contract development and manufacturing organization (CDMO), announces Yuk Chun Chiu as Vice...

Next Page keyboard_arrow_right